Effect of metabolic inhibitors and ouabain on amphetamine- and potassium-induced release of biogenic amines from isolated brain tissue.
D000255:Adenosine Triphosphate / Q000378:metabolism / Q000502:physiology; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D003913:Dextroamphetamine / Q000494:pharmacology*; D004347:Drug Interactions; D066298:In Vitro Techniques; D010042:Ouabain / Q000494:pharmacology*; D011188:Potassium / Q000494:pharmacology*; D051381:Rats
D000963:Antimetabolites; D001679:Biogenic Amines; D010042:Ouabain; D000255:Adenosine Triphosphate; D011188:Potassium; D003913:Dextroamphetamine